Who owns MONTE ROSA THERAPEUTICS INC?
- Ticker: GLUE
- CUSIP Number: 61225m102
Tip: Access positions for across all investors
Analyze quarterly positions in Monte Rosa Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Monte Rosa Therapeutics stock
Who bought or sold MONTE ROSA THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| NEA Management Company | 7.7M | $41M | 0% | Sep 2024 |
|
| T. Rowe Price Associates | 6.6M | $35M | 10% | Sep 2024 |
|
| Baker Bros. Advisors | 4.9M | $26M | 0% | Sep 2024 |
|
| BlackRock | 2.9M | $15M | 100% | Sep 2024 |
|
| Suvretta Capital Management | 2.7M | $9.9M | 100% | Jun 2024 |
|
| Vanguard Group | 2.5M | $9.5M | 56% | Jun 2024 |
|
| BlackRock | 2.4M | $8.8M | 2% | Jun 2024 |
|
| Aisling Capital Management | 1.5M | $5.5M | 0% | Jun 2024 |
|
| Alphabet | 1.5M | $7.8M | 0% | Sep 2024 |
|
| Citadel Advisors | 1.3M | $6.7M | 24% | Sep 2024 |
|
| Geode Capital Management | 1.0M | $5.5M | 23% | Sep 2024 |
|
| Vestal Point Capital | 930k | $4.9M | 4% | Sep 2024 |
|
| State Street Corporation | 636k | $2.4M | 3% | Jun 2024 |
|
| Parkwood | 427k | $2.3M | 100% | Sep 2024 |
|
| ExodusPoint Capital Management | 394k | $2.1M | 48% | Sep 2024 |
|
| Sphera Funds Management | 375k | $1.4M | 100% | Jun 2024 |
|
| Northern Trust | 359k | $1.9M | 23% | Sep 2024 |
|
| Charles Schwab Investment Management | 347k | $1.8M | 11% | Sep 2024 |
|
| Ikarian Capital | 312k | $1.7M | 100% | Sep 2024 |
|
| Renaissance Technologies | 219k | $1.2M | -14% | Sep 2024 |
|
| TD Asset Management | 194k | $1.0M | 0% | Sep 2024 |
|
| Marshall Wace | 174k | $921k | 100% | Sep 2024 |
|
| Bank of New York Mellon | 167k | $884k | 52% | Sep 2024 |
|
| Dimensional Fund Advisors | 139k | $738k | -9% | Sep 2024 |
|
| Acadian Asset Management | 111k | $586k | 12% | Sep 2024 |
|
| Manufacturers Life Insurance Company | 103k | $384k | 0% | Jun 2024 |
|
| Goldman Sachs Group | 92k | $345k | 486% | Jun 2024 |
|
| Nuveen Asset Management | 89k | $333k | 0% | Jun 2024 |
|
| Casdin Capital | 86k | $456k | -67% | Sep 2024 |
|
| Bank of America Corporation | 73k | $389k | 7% | Sep 2024 |
|
| Susquehanna International | 71k | $377k | -16% | Sep 2024 |
|
| Morgan Stanley | 68k | $256k | 23% | Jun 2024 |
|
| American Century Companies | 60k | $320k | 22% | Sep 2024 |
|
| Barclays | 55k | $289k | 395% | Sep 2024 |
|
| Rhumbline Advisers | 53k | $278k | 9% | Sep 2024 |
|
| Long Corridor Asset Management | 40k | $212k | 0% | Sep 2024 |
|
| Hrt Financial | 39k | $206k | 100% | Sep 2024 |
|
| EntryPoint Capital | 33k | $176k | 100% | Sep 2024 |
|
| Alliancebernstein | 33k | $123k | 39% | Jun 2024 |
|
| Citigroup | 30k | $160k | 216% | Sep 2024 |
|
| Exchange Traded Concepts | 30k | $158k | -16% | Sep 2024 |
|
| MetLife Investment Advisors | 25k | $132k | 100% | Sep 2024 |
|
| Squarepoint Ops | 23k | $85k | 100% | Jun 2024 |
|
| Mirae Asset Global Etfs Holdings | 23k | $120k | 39% | Sep 2024 |
|
| Deutsche Bank Aktiengesellschaft | 22k | $119k | 107% | Sep 2024 |
|
| Wells Fargo & Company | 22k | $118k | 36% | Sep 2024 |
|
| Sherbrooke Park Advisers | 20k | $106k | 100% | Sep 2024 |
|
| CornerCap Investment Counsel | 19k | $102k | -54% | Sep 2024 |
|
| Jpmorgan Chase & Co | 19k | $98k | 38% | Sep 2024 |
|
| D. E. Shaw & Co | 18k | $97k | -22% | Sep 2024 |
|
| Jane Street | 17k | $89k | -75% | Sep 2024 |
|
| Qube Research & Technologies | 17k | $62k | 100% | Jun 2024 |
|
| Florida State Board of Administration | 15k | $79k | 0% | Sep 2024 |
|
| Intech Investment Management | 15k | $77k | 100% | Sep 2024 |
|
| Tower Research Capital | 14k | $50k | 2477% | Jun 2024 |
|
| Ing Investment Management | 13k | $70k | 18% | Sep 2024 |
|
| New York State Common Retirement Fund | 12k | $65k | 0% | Sep 2024 |
|
| SG Americas Securities | 10k | $55k | 100% | Sep 2024 |
|
| Meeder Asset Management | 10k | $53k | 0% | Sep 2024 |
|
| Royal Bank of Canada | 4.5k | $21k | 7% | Sep 2024 |
|
| Summit Investment Advisors | 4.2k | $22k | 87% | Sep 2024 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 3.1k | $16k | 0% | Sep 2024 |
|
| California State Teachers Retirement System | 3.0k | $16k | 38% | Sep 2024 |
|
| NISA Investment Advisors | 2.8k | $15k | 1% | Sep 2024 |
|
| Russell Investments | 2.6k | $9.8k | 100% | Jun 2024 |
|
| Advisor Group Holdings | 1.1k | $5.6k | 164% | Sep 2024 |
|
| Amalgamated Bank | 995.00 | $5.0k | 0% | Sep 2024 |
|
| Brian McDonald | 841.00 | $4.5k | 0% | Sep 2024 |
|
| Northwestern Mutual Wealth Management Company | 300.00 | $1.6k | 0% | Sep 2024 |
|
| Sterling Capital Management | 147.00 | $778.997100 | 100% | Sep 2024 |
|
| CWM | 56.00 | $0 | 167% | Sep 2024 |
|
| GAMMA Investing | 55.00 | $292.000500 | 6% | Sep 2024 |
|
| Capital Performance Advisors | 29.00 | $153.998700 | 100% | Sep 2024 |
|
| Pnc Financial Services | 28.00 | $147.999600 | 0% | Sep 2024 |
|
Who sold out of Monte Rosa Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Sarasin & Partners | Jun 2024 | 65k | $243k |
| GSA Capital Partners | Jun 2024 | 25k | $95k |
| Millennium Management | Jun 2024 | 21k | $78k |
| Castleview Partners | Jun 2024 | 19k | $71k |
| Jump Financial | Jun 2024 | 16k | $61k |